Herlev Hospital

Herlev, Capital 2730

0 studies enrolling now · 2 studies all time

What they study most

Autologous Stem Cell Transplant, Carcinoma, Renal Cell, Multiple Myeloma

Studies at this site

• A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant — Completed
• A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC) — Completed